Follow
Markus Welcker
Markus Welcker
Unknown affiliation
Verified email at fredhutch.org
Title
Cited by
Cited by
Year
FBW7 ubiquitin ligase: a tumour suppressor at the crossroads of cell division, growth and differentiation
M Welcker, BE Clurman
Nature Reviews Cancer 8 (2), 83-93, 2008
12032008
Rapid destruction of human Cdc25A in response to DNA damage
N Mailand, J Falck, C Lukas, RG Syljuåsen, M Welcker, J Bartek, J Lukas
Science 288 (5470), 1425-1429, 2000
10752000
The Fbw7 tumor suppressor regulates glycogen synthase kinase 3 phosphorylation-dependent c-Myc protein degradation
M Welcker, A Orian, J Jin, JA Grim, JW Harper, RN Eisenman, ...
Proceedings of the National Academy of Sciences 101 (24), 9085-9090, 2004
10272004
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
J O'Neil, J Grim, P Strack, S Rao, D Tibbitts, C Winter, J Hardwick, ...
The Journal of experimental medicine 204 (8), 1813-1824, 2007
7902007
Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation
M Welcker, J Singer, KR Loeb, J Grim, A Bloecher, M Gurien-West, ...
Molecular cell 12 (2), 381-392, 2003
4742003
A nucleolar isoform of the Fbw7 ubiquitin ligase regulates c-Myc and cell size
M Welcker, A Orian, JA Grim, RN Eisenman, BE Clurman
Current Biology 14 (20), 1852-1857, 2004
3682004
Tumor suppression by the Fbw7 ubiquitin ligase: mechanisms and opportunities
RJ Davis, M Welcker, BE Clurman
Cancer cell 26 (4), 455-464, 2014
3652014
Kinase-independent function of cyclin E
Y Geng, YM Lee, M Welcker, J Swanger, A Zagozdzon, JD Winer, ...
Molecular cell 25 (1), 127-139, 2007
2162007
Identification of CDK2 substrates in human cell lysates
Y Chi, M Welcker, AA Hizli, JJ Posakony, R Aebersold, BE Clurman
Genome biology 9, 1-12, 2008
1912008
Fbw7/hCDC4 dimerization regulates its substrate interactions
M Welcker, BE Clurman
Cell division 2, 1-13, 2007
1532007
Recognition of phosphodegron motifs in human cyclin E by the SCFFbw7 ubiquitin ligase
X Ye, G Nalepa, M Welcker, BM Kessler, E Spooner, J Qin, SJ Elledge, ...
Journal of Biological Chemistry 279 (48), 50110-50119, 2004
1532004
p53 and p21 form an inducible barrier that protects cells against cyclin E-cdk2 deregulation
AC Minella, J Swanger, E Bryant, M Welcker, H Hwang, BE Clurman
Current Biology 12 (21), 1817-1827, 2002
1482002
Cyclin D2 is a moderately oscillating nucleoprotein required for G1 phase progression in specific cell types.
J Lukas, J Bartkova, M Welcker, OW Petersen, G Peters, M Strauss, ...
Oncogene 10 (11), 2125-2134, 1995
1471995
Isoform-and cell cycle–dependent substrate degradation by the Fbw7 ubiquitin ligase
JE Grim, MP Gustafson, RK Hirata, AC Hagar, J Swanger, M Welcker, ...
The Journal of cell biology 181 (6), 913-920, 2008
1352008
Fbw7 dimerization determines the specificity and robustness of substrate degradation
M Welcker, EA Larimore, J Swanger, MT Bengoechea-Alonso, JE Grim, ...
Genes & development 27 (23), 2531-2536, 2013
1102013
Cyclin E phosphorylation regulates cell proliferation in hematopoietic and epithelial lineages in vivo
AC Minella, KR Loeb, A Knecht, M Welcker, BJ Varnum-Finney, ...
Genes & development 22 (12), 1677-1689, 2008
1072008
The SV40 Large T Antigen Contains a Decoy Phosphodegron That Mediates Its Interactions with Fbw7/hCdc4*♦
M Welcker, BE Clurman
Journal of Biological Chemistry 280 (9), 7654-7658, 2005
1052005
Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A–cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase
AA Hizli, Y Chi, J Swanger, JH Carter, Y Liao, M Welcker, AG Ryazanov, ...
Molecular and cellular biology, 2013
1022013
Ras activity regulates cyclin E degradation by the Fbw7 pathway
AC Minella, M Welcker, BE Clurman
Proceedings of the National Academy of Sciences 102 (27), 9649-9654, 2005
792005
Enhanced protein stability: a novel mechanism of D-type cyclin over-abundance identified in human sarcoma cells.
M Welcker, J Lukas, M Strauss, J Bartek
Oncogene 13 (2), 419-425, 1996
711996
The system can't perform the operation now. Try again later.
Articles 1–20